The Austin region’s mobile coronavirus antibody infusion center has been in operation since January 6. At the time it opened, it had the capacity to hold nine patients, but thanks to some assistance from the Texas Division of Emergency Management, the center is expanding its capabilities. 24 additional chairs have been provided to the center, along with increased staffing and supplies.
The site treats patients currently infected with coronavirus — most of whom are age 65 and older — with COVID-19 antibodies that have been shown to limit symptoms, and in many cases eliminate the need for hospitalization.
“These treatments are essential in our fight to keep hospitalizations down and save lives,” said Governor Greg Abbott.
The infusion center will be kept stocked through a collaboration with Baylor Scott & White, Ascension Seton, and St. David’s. The hospital systems have released a joint statement which reads in part:
“The center will become the primary outpatient infusion clinic for the region, with a goal of providing optimal patient treatment outside of the hospital setting while allowing hospital staff to focus on caring for critical COVID patients.”
As of Monday, a total of 279 patients had been treated. 33 patients will now be able to be treated simultaneously.
For more information about the Austin Regional Infusion Center visit: http://catrac.org/infusioncenter/
